Effect of cigarette smoking on plasma metalloproteinase-9 concentration

Clinica Chimica Acta

Volumn 276, Issue 2, 1998, Pages 173-177

  Nakamura, Tsukasa ^a   Ebihara, Isao ^b   Shimada, Noriaki ^b   Koide, Hikaru ^b  

^a Misato Junshin Hospital   (Japan)

^b KOTO HOSPITAL   (Japan)

Author keywords

Lung cancer; Metalloproteinase; Smoking

Indexed keywords

METALLOPROTEINASE;

ADULT; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; ENZYME BLOOD LEVEL; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN EXPERIMENT; LUNG CANCER; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; COLLAGENASES; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; SMOKING;

NICOTIANA TABACUM;

EID: 0031711994     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(98)00104-1     Document Type: Article

References (14)

1. Wilhelm S.M., Collier I.E., Mariner B.L., Eisen A.Z., Grant G.A., Goldberg G.I. 5V40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem. 264:1989;17213-17222.
2. Moutsiakis D., Mancuso P., Krutzsch H., Stetler-Stevenson W., Zucker S. Characterization of metalloproteinases and tissue inhibitors of metalloproteinases in human plasma. Connect Tissue Res. 28:1992;213-220.
3. Ballin M., Gomez D.E., Sinha C.C., Thorgeirsson U.P. Ras oncogene mediated induction of a 92kDa metalloproteinase: Strong correlation with the malignant phenotype. Biochem Biophys Res Commun. 154:1988;832-838.
4. Welgus H.G., Campbell E.J., Cury J.D.et al. Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile regulation and expression during cellular development. J Clin Invest. 86:1990;1496-1502.
5. Okada Y., Naka K., Kawamura K.et al. Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase=gelatinase B) in osteoclasts: Implications for bone resorption. Lab Invest. 72:1995;311-322.
6. Koide H., Nakamura T., Ebihara I., Tomino Y. Increased mRNA expression of MMP-9 in peripheral blood monocytes from patients with IgA nephropathy. Am J Kidney Diseases. 28:1996;32-39.
7. Ebihara I., Nakamura T., Tomino Y., Shimada N., Koide H. Metalloproteinase-9 mRNA expression in monocytes from patients with chronic renal failure. Am J Nephrol, 18:1998;305-310.
8. Toni A., Kodera Y., Uesaka K.et al. Matrix metalloproteinase 9 in human plasma has 96% specificity and 56% sensitivity for gastric cancer screening. Int J Clin Oncol. 1:1996;39-43.
9. Fujimoto N., Hosokawa N., Iwata K., Shinya T., Okada Y., Hayakawa T. A one-step sandwich enzyme immunoassay for inactive precursor and complexed forms of human matrix metalloproteinase 9 (92 kDa gelatinase/type IC collagenase gelatinase B) using monoclonal antibodies. Clin Chim Acta. 231:1994;79-88.
10. Murphy G., Ward R., Hembry R.M., Reynolds J.J., Kuhn K., Tryggvason K. Characterization of gelatinase from pig polymorphonuclear leukocytes. A metalloproteinase resembling tumor type IV collagenase. Biochem J. 258:1989;463-472.
11. Okada Y., Morodomi T., Enghild J.J., Suzuki K., Yasui A., Nakanishi I. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. Eur J Biochem. 194:1990;721-730.
12. Howard E.W., Bullen E.C., Banda M.J. Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinase-2. J Biol Chem. 266:1991;13064-13069.
13. Sato H., Kida Y., Mai M.et al. Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitor of metalloproteinases in various human tumor cells. Oncogene. 7:1992;77-83.
14. Fujimoto N., Mouri N., Iwata K., Ohuchi E., Okada Y., Hayakawa T. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 using monoclonal antibodies. Clin Chim Acta. 221:1993;91-103.